Evaluation of the therapeutic synergy between tacrolimus and nitroglycerin in an imiquimod-induced psoriasis mouse model
Bulletin of the Russian Military Medical Academy · 25.10.2026 · 28 (4) · 569-581
DOI: 10.17816/brmma700552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of the Russian Military Medical Academy, online erschienen am 25.10.2026. Verfasst von Mohammed Abdul Muttalib Abdul Bari. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Psoriasis is a chronic, immune-mediated inflammatory skin disease affecting 2–3% of the population worldwide, characterized by keratinocyte hyperproliferation and inflammation driven by TNF-α, IL-17 and IL-23. Topical agents are the mainstay of treatment in mild disease, but prolonged corticosteroid use causes well-recognized adverse effects. Tacrolimus, a steroid-sparing calcineurin inhibitor, is effective yet limited by poor penetration through thick psoriatic plaques. Nitroglycerin, a nitric oxide (NO) donor, may enhance cutaneous drug penetration. AIM: This study assessed whether combining topical tacrolimus with nitroglycerin improves therapeutic outcomes in an imiquimod-induced murine model of psoriasis. METHODS: Psoriasis-like dermatitis was induced on the dorsal skin of BALB/c mice by daily application of 5% imiquimod cream for six days. Mice were allocated to treatment groups receiving either 0.1% tacrolimus alone or a combination of 0.1% tacrolimus and approximately 2% nitroglycerin. Outcomes were evaluated by clinical severity scoring, histopathology, and tissue TNF-α and IL-6 levels. RESULTS: The tacrolimus–nitroglycerin combination substantially improved clinical and histological recovery relative to tacrolimus alone, most likely through enhanced cutaneous penetration and direct NO-mediated effects, despite no further reduction in TNF-α or IL-6. CONCLUSION: This combination represents a promising steroid-sparing topical strategy for psoriasis/
Zitieren
APA
Bari, M. A. M. A. (2026). Evaluation of the therapeutic synergy between tacrolimus and nitroglycerin in an imiquimod-induced psoriasis mouse model. Bulletin of the Russian Military Medical Academy, 28(4), 569-581. https://doi.org/10.17816/brmma700552
Vancouver
Bari MAMA. Evaluation of the therapeutic synergy between tacrolimus and nitroglycerin in an imiquimod-induced psoriasis mouse model. Bulletin of the Russian Military Medical Academy. 2026;28(4):569-581. doi:10.17816/brmma700552
BibTeX
@article{Bari2026,
author = {Bari, Mohammed Abdul Muttalib Abdul},
title = {Evaluation of the therapeutic synergy between tacrolimus and nitroglycerin in an imiquimod-induced psoriasis mouse model},
journal = {Bulletin of the Russian Military Medical Academy},
year = {2026},
volume = {28},
number = {4},
pages = {569--581},
doi = {10.17816/brmma700552}
}
EUVIMED